Stock 2105 LAEKNA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Laekna, Inc.

Equities

2105

KYG5340S1093

Delayed Hong Kong S.E.
Other stock markets
 11:46:10 2024-07-16 pm EDT 		5-day change 1st Jan Change
4.96 HKD +1.22% Intraday chart for Laekna, Inc. -2.55% -75.08%
Jun. 26 Laekna Administers First Dose of Weight Loss Drug in China During Phase I Clinical Trials; Shares Gain 6% MT
Jun. 26 Laekna, Inc Doses Subject in Phase I Clinical Trial of LAE102 for the Treatment of Obesity CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
LAEKNA, INC. Stock Laekna, Inc.
 245M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 126B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 118B
ARGENX SE Stock argenx SE
 27.87B -
BIONTECH SE Stock BioNTech SE
 20.95B -
GENMAB A/S Stock Genmab A/S
 16.92B
  1. Stock Market
  2. Equities
  3. 2105 Stock
  4. Charts Laekna, Inc.
  5. Sector Chart